510(k) K063845
K063845 is an FDA 510(k) premarket notification submitted by Bayer Healthcare, LLC for the device "ADVIA CHEMISTRY TOTAL BILIRUBIN_2". The FDA issued a decision of Substantially Equivalent on December 7, 2007. The device falls under product code JFM (Enzymatic Method, Bilirubin), a Class II device regulated under 21 CFR 862.1110. Bayer Healthcare, LLC has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- December 7, 2007
- Date Received
- December 27, 2006
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Enzymatic Method, Bilirubin
- Device Class
- Class II
- Regulation Number
- 862.1110
- Review Panel
- CH
- Submission Type